-

Dr. David Krajicek Joins Summit Partners as Executive-in-Residence

LONDON--(BUSINESS WIRE)--Global growth equity investor Summit Partners is delighted to welcome Dr. David Krajicek to the firm’s Executive-in-Residence (“EIR”) program. In this role, Dr. Krajicek will work closely with Summit’s Growth Products & Services team to identify new investment opportunities and advise growth-stage companies within the data and analytics sector.

Dr. Krajicek is an experienced operator who has built and led data and analytics companies for more than 25 years. Most recently, he served as CEO of JATO, an automotive data company, where he led meaningful value creation initiatives centered around technology enhancement, new product launches and improved go-to-market. Dr. Krajicek joined JATO following a 14-year tenure with GfK, a global market research and analytics company where he held several executive roles, leading teams of several thousand people and managing a nearly $1 billion P&L. In 2017, GfK was acquired in a take-private transaction valued at $1.5 billion. As part of GfK’s global management board, Dr. Krajicek was named CEO of the company’s research division, leading it through its transformation and sale to Ipsos. Prior to GfK, Dr. Krajicek spent nearly a decade at ARBOR, a U.S.-based data-led market research firm. During his tenure at ARBOR, the business underwent transformative growth, scaling 30-fold and ultimately resulting in an acquisition by GfK. Dr. Krajicek holds a BA in cognitive psychology from UC San Diego and an MA and PhD in cognitive psychology from Claremont Graduate University.

“We are confident that David’s deep understanding of data and analytics companies and his extensive operating experience will both serve to support Summit’s efforts in identifying and partnering with leading growth companies in this dynamic sector,” said Chris Bon, Principal at Summit Partners. “We are thrilled to welcome David to our EIR program, and we look forward to sharing his skillset and experience with the entrepreneurs and executives with whom we partner.”

“Summit's commitment to driving growth in the data and analytics sector aligns well with my passion for fostering innovation and success in this space,” said Dr. Krajicek. “I look forward to contributing to the firm’s ongoing efforts and helping growth-stage companies achieve their full potential."

With a focus on investing in category-leading growth businesses across key sectors, Summit has partnered with numerous data and analytics companies, providing support on product and technology initiatives, geographic expansion and other strategic initiatives to help drive meaningful growth.

Summit’s EIR program is an established element of the firm’s growth-oriented investing strategy. Since its inception, the program has facilitated collaboration between seasoned industry executives and Summit’s investment professionals, working to identify sector-specific opportunities in which EIRs may support companies in an ongoing capacity through board or executive leadership roles.

About Summit Partners

Founded in 1984, Summit Partners is a global alternative investment firm with capital dedicated to growth equity, fixed income, and public equity opportunities. Summit invests across growth sectors of the economy and has invested in more than 550 companies in technology, healthcare, and other growth industries. Summit maintains offices in North America and Europe and invests in companies around the world. For more information, please see summitpartners.com or follow on LinkedIn.

Contacts

Media Contact:
Susan Barr | sbarr@summitpartners.com

Summit Partners


Release Versions

Contacts

Media Contact:
Susan Barr | sbarr@summitpartners.com

Social Media Profiles
More News From Summit Partners

Summit Partners Announces Growth Investment in Dreampath Diagnostics to Accelerate Digital Transformation in Anatomical Pathology

LONDON & BOSTON & STRASBOURG, France--(BUSINESS WIRE)--Summit Partners today announced a growth investment in Dreampath Diagnostics, a leading healthcare technology company focused on digitizing workflows in anatomical pathology laboratories. The investment will support the company’s plans to accelerate global growth, scale operations and expand its commercial reach and product portfolio. Founded in 2012, Dreampath offers a patented suite of traceability solutions and consumables designed to au...

RIS Rx Announces Growth Investment from Summit Partners to Combat Revenue Leakage in Pharma Patient Affordability Programs

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--RIS Rx, a healthcare technology company pioneering solutions to reduce revenue leakage in pharmaceutical gross-to-net spread, today announced a significant growth investment from Summit Partners. This partnership will support RIS Rx’s continued innovation and growth in service of the company’s commitment to improving patient access to treatment, one prescription at a time. Founded in 2020 by pharmacists Gerard Rivera and Stephen Hom, RIS Rx was born out o...

Simply.TV Expands in North America with Acquisition of Red Bee Media’s Content Discovery Business and Announces Growth Investment from Summit Partners

COPENHAGEN, Denmark--(BUSINESS WIRE)--Simply.TV, a leading video metadata provider, today announced the acquisition of Red Bee Media’s Content Discovery Business, further accelerating Simply.TV’s global expansion and strengthening the company’s position in the U.S. market. In conjunction with this acquisition, Simply.TV has secured a majority growth equity investment from Summit Partners, marking the company’s first institutional funding. Founded in 2019 by Morten Trolle and Daniel Rühmann, Sim...
Back to Newsroom